Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
Navigating Presbyopia Conversations with Patients in Practice
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Dry eye symptom questionnaires may not be interchangeable
  • Ocular Surface Disease

Dry eye symptom questionnaires may not be interchangeable

Optometry 360

The Ocular Surface Disease Index (OSDI) and Standard Patient Evaluation of Eye Dryness (SPEED) questionnaires showed moderate correlation but poor agreement in patients with dry eye disease, suggesting they should not be used interchangeably, according to a study. Both questionnaires also showed weak associations with objective clinical signs.

This retrospective chart review included 3337 adults evaluated at a tertiary dry eye clinic between 2019 and 2025. Ocular Surface Disease Index and SPEED scores were moderately correlated (ρ = 0.53; P < .001), but agreement was poor after rescaling, with a concordance correlation coefficient of 0.38.

Both questionnaires demonstrated high internal consistency (OSDI α = 0.89; SPEED α = 0.87). However, higher OSDI scores were associated with tear film homeostasis loss (P = 0.001), while SPEED scores were not (P = 0.86).

Researchers concluded that the questionnaires are not interchangeable and that assessing dry eye disease requires consideration of both patient-reported symptoms and objective clinical signs.

Reference

Abdel-Sayyed A, Alizada A, Al-Ani A, et al. Agreement and clinical alignment of the Ocular Surface Disease Index and Standard Patient Evaluation of Eye Dryness in a large dry eye clinic cohort. Can J Ophthalmol. 2026;S0008-4182(26)00378-9. doi: 10.1016/j.jcjo.2026.10.002. Epub ahead of print. PMID: 42998674.

Share

Related Content

  • Ocular Surface Disease

Phase 3 trial finds comparable efficacy with 5% diquafosol dosed 3 times daily

  • Ocular Surface Disease

Topical azithromycin shows benefit in mixed dry eye disease

  • Ocular Surface Disease

Full-spectrum lamp improves short-term symptoms of VDT-related dry eye

  • Ocular Surface Disease

DEWS III updates classification of dry eye disease risk factors

  • Ocular Surface Disease

Check the labels: products containing vitamin A can carry a risk of ocular adverse effects and MGD

  • Conference Roundup

Cash-pay dry eye marketing often outpaces available evidence

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon